Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia

Hurt, Christopher Nicholas ORCID: https://orcid.org/0000-0003-1206-8355, Nedjai, Belinda, Alvarez-Mendoza, Carlos, Powell, Ned, Tristram, Amanda and Jones, Sadie 2022. Combined HPV 16 E2 and L1 methylation predict response to treatment with cidofovir and imiquimod in patients with vulval intraepithelial neoplasia. Cancer Biomarkers 35 , pp. 143-153. 10.3233/CBM-210448

[thumbnail of cbm_2022_35-2_cbm-35-2-cbm210448_cbm-35-cbm210448.pdf]
Preview
PDF - Published Version
Available under License Creative Commons Attribution.

Download (992kB) | Preview
License URL: http://creativecommons.org/licenses/by/4.0/
License Start date: 12 October 2022

Abstract

BACKGROUND: Topical cidofovir and imiquimod can effectively treat approximately 55% of patients with vulval intraepithelial neoplasia (VIN), thus avoiding the need for surgery. Human papillomavirus (HPV) E⁢2 gene methylation predicts response to treatment but a methylation measurement is only obtainable in approximately 50% of patients. OBJECTIVE: This work aimed to determine if the applicability and predictive power of the E⁢2 methylation assay could be improved by combining it with the components of a host and viral DNA methylation panel (S5) that has been found to predict disease progression in patients with cervical intraepithelial neoplasia. METHODS: HPV E2 methylation and S5 classifier score were measured in fresh tissue samples collected pre-treatment from 132 patients with biopsy-proven VIN grade 3 who participated in a multicentre clinical trial and were randomised to treatment with cidofovir or imiquimod. RESULTS: Combining HPV16 E⁢2 and HPV16 L⁢1 methylation provides a biomarker that is both predictive of response to topical treatment and that can produce a clinically applicable result for all patients. Patients with HPV 16 L⁢1ℎ

Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Centre for Trials Research (CNTRR)
Publisher: IOS Press
ISSN: 1875-8592
Funders: CRUK
Date of First Compliant Deposit: 31 August 2022
Date of Acceptance: 24 June 2022
Last Modified: 21 Oct 2023 01:07
URI: https://orca.cardiff.ac.uk/id/eprint/152240

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics